Modern management of heart failure.
The biochemistry and pathophysiology of ventricular dysfunction leading to cardiac failure, and the importance of abnormal peripheral haemodynamics and altered neurohumoral mechanisms, are now better understood. Treatment has been rationalised and the place of vasodilators, particularly converting-enzyme inhibitors, has been established. There is no evidence that prognosis has been improved despite symptomatic improvement in the patient with heart failure.